Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
2.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Kidney Int
; 100(1): 225-237, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307104
3.
Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis.
BMC Nephrol
; 22(1): 5, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407224
4.
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Kidney Int
; 104(1): 205, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349053
5.
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
Breast Cancer Res Treat
; 165(3): 601-609, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681171
6.
Correction to: Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis.
BMC Nephrol
; 22(1): 49, 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33530925
7.
Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administration.
Int J Clin Pharmacol Ther
; 51(8): 688-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23782582
8.
Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia.
Bone
; 142: 115664, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987199
9.
Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
Bone
; 121: 149-162, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576866
10.
Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects.
J Clin Pharmacol
; 58(2): 254-262, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884824
11.
Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates.
Clin Drug Investig
; 25(2): 107-14, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17523760
12.
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
J Clin Endocrinol Metab
; 99(11): E2207-15, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25166719
13.
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Menopause
; 21(9): 938-44, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569618
14.
A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humans.
J Bone Miner Res
; 28(8): 1830-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436611
15.
Odanacatib does not influence the single dose pharmacokinetics and pharmacodynamics of warfarin.
J Popul Ther Clin Pharmacol
; 20(3): e312-20, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142206
16.
Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study.
J Bone Miner Res
; 27(11): 2251-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777865
17.
Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet.
J Clin Pharmacol
; 51(10): 1439-48, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148044
18.
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children.
Clin Ther
; 33(10): 1516-23, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21962451
19.
Effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the steady-state pharmacokinetics of digoxin in healthy adult subjects.
J Clin Pharmacol
; 50(7): 823-8, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197486
20.
Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist.
Adv Ther
; 26(2): 230-40, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19219408